WO2013004895A1 - Milk-based formulation - Google Patents
Milk-based formulation Download PDFInfo
- Publication number
- WO2013004895A1 WO2013004895A1 PCT/FI2012/050634 FI2012050634W WO2013004895A1 WO 2013004895 A1 WO2013004895 A1 WO 2013004895A1 FI 2012050634 W FI2012050634 W FI 2012050634W WO 2013004895 A1 WO2013004895 A1 WO 2013004895A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- milk
- protein
- based formulation
- recombined
- content
- Prior art date
Links
- 235000013336 milk Nutrition 0.000 title claims abstract description 171
- 239000008267 milk Substances 0.000 title claims abstract description 171
- 210000004080 milk Anatomy 0.000 title claims abstract description 171
- 239000000203 mixture Substances 0.000 title claims abstract description 77
- 238000009472 formulation Methods 0.000 title claims abstract description 57
- 235000020201 recombined milk Nutrition 0.000 claims abstract description 64
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 58
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 58
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 49
- 239000008101 lactose Substances 0.000 claims abstract description 49
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 49
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 49
- 230000002829 reductive effect Effects 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 33
- 239000002994 raw material Substances 0.000 claims abstract description 28
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 239000007858 starting material Substances 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims description 73
- 239000000843 powder Substances 0.000 claims description 70
- 235000013361 beverage Nutrition 0.000 claims description 58
- 235000018102 proteins Nutrition 0.000 claims description 46
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 31
- 239000011707 mineral Substances 0.000 claims description 31
- 235000020183 skimmed milk Nutrition 0.000 claims description 29
- 238000000108 ultra-filtration Methods 0.000 claims description 28
- 239000012465 retentate Substances 0.000 claims description 27
- 238000001728 nano-filtration Methods 0.000 claims description 24
- 238000001223 reverse osmosis Methods 0.000 claims description 22
- 239000012466 permeate Substances 0.000 claims description 21
- 238000010438 heat treatment Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 8
- 108010011756 Milk Proteins Proteins 0.000 claims description 7
- 102000014171 Milk Proteins Human genes 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 7
- 235000021239 milk protein Nutrition 0.000 claims description 7
- 235000020124 milk-based beverage Nutrition 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 238000013375 chromatographic separation Methods 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000000727 fraction Substances 0.000 claims description 3
- 235000013861 fat-free Nutrition 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 229940077731 carbohydrate nutrients Drugs 0.000 claims 9
- 230000007812 deficiency Effects 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- YQHPCDPFXQXCMV-VIFPVBQESA-N (2s)-2-amino-6-[[2-(furan-2-yl)-2-oxoethyl]amino]hexanoic acid Chemical compound OC(=O)[C@@H](N)CCCCNCC(=O)C1=CC=CO1 YQHPCDPFXQXCMV-VIFPVBQESA-N 0.000 description 12
- ZOEGQXCAXOUFHN-UHFFFAOYSA-N Furosin Natural products OC1C2OC(=O)C(C=3C4C5(O)O)=CC(O)=C(O)C=3OC5(O)C(=O)C=C4C(=O)OC1C(CO)OC2OC(=O)C1=CC(O)=C(O)C(O)=C1 ZOEGQXCAXOUFHN-UHFFFAOYSA-N 0.000 description 12
- 230000007062 hydrolysis Effects 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 7
- 108010046377 Whey Proteins Proteins 0.000 description 6
- 235000020190 lactose-free milk Nutrition 0.000 description 6
- 108010059881 Lactase Proteins 0.000 description 5
- 239000005862 Whey Substances 0.000 description 5
- 102000007544 Whey Proteins Human genes 0.000 description 5
- 108010005774 beta-Galactosidase Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- 102100026189 Beta-galactosidase Human genes 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000003729 cation exchange resin Substances 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940116108 lactase Drugs 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000021243 milk fat Nutrition 0.000 description 2
- 229940029985 mineral supplement Drugs 0.000 description 2
- 235000020786 mineral supplement Nutrition 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000019581 fat taste sensations Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019869 fractionated palm oil Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000020121 low-fat milk Nutrition 0.000 description 1
- 235000020184 organic milk Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940070376 protein Drugs 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000007847 structural defect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/005—Condensed milk; Sugared condensed milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
- A23C9/1206—Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1427—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
- A23C9/1508—Dissolving or reconstituting milk powder; Reconstitution of milk concentrate with water; Standardisation of fat content of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/18—Milk in dried and compressed or semi-solid form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C2210/00—Physical treatment of dairy products
- A23C2210/25—Separating and blending
- A23C2210/252—Separating a milk product in at least two fractions followed by treatment of at least one of the fractions and remixing at least part of the two fractions
Definitions
- the present invention relates to milk-based formulations. More particularly, the invention relates to milk-based formulations which are suitable for the preparation of recombined milk products with a reduced carbohydrate content.
- recombined milk beverages prepared by re- combining milk powder and water have several defects compared to normal milk. Deficiencies appear especially in the preparation of recombined milk beverages with reduced lactose contents.
- the deficiencies are both organoleptical and nutritional in nature.
- the recombined milk beverages are susceptible to form precipitates/sediments during heat treatment, and especially during storage of the beverages.
- the precipitated matter is mainly consisted of milk proteins. It is known that among milk proteins, whey proteins especially are very heat-sensitive. Certain minerals may also have an influence on the precipitation phenomenon of the recombined milk beverages.
- the problems associated with the sensitivity of precipitation of the recombined milk products, agglomeration has been avoided by using additives like stabilizers in the products.
- Low lactose or lactose-free milk beverages can be prepared from re- combined milk beverages by hydrolyzing the lactose thereof.
- the amount of natural lactose content is relatively high, which means that the hydrolysis of lactose produces a great amount of glucose and galactose imparting an uncommon sweet taste to the product.
- the Maillard reaction is a nonenzymatic browning reaction between reducing sugars and free amino groups of milk proteins.
- the Maillard reaction is a common problem especially in lactose-hydrolyzed milk products. Reducing sugars, glucose and galactose, produced in lactose hydrolysis are more reactive than lactose, thus causing stronger Maillard browning reaction.
- hydro- lyzed milk the molar content of these reducing monosaccharides is almost double in comparison with that of regular milk lactose. It is further known that the Maillard reaction becomes even stronger during heat treatment of the lactose- hydrolyzed milk products.
- the Maillard browning products cause an undesirable change in the organoleptic properties of the heat-treated milk, such as taste, colour, and struc- ture.
- the Maillard reaction has a detrimental effect on the nutritional quality of milk. Bioavailability of lysine which is an important amino acid for the nutritional value is reduced.
- the Maillard reaction and destruction of lysine continues during the storage at a room temperature after the heat treatment of the milk product.
- the Maillard reaction can be monitored by furosine, which presents products formed in the reactions between free amino groups and reducing sugars, and resulting in a loss of their availability.
- the invention provides a milk-based formulation with a reduced carbohydrate content, having a ratio of carbohydrates to protein of at most 1 .1 , a protein content of at least 5.4% on dry matter basis, and a ratio of ash to protein is substantially similar to that of a milk raw material used as a starting material. It was surprisingly found that the defects in organoleptic properties, like precipitation and defects in taste, and nutritional quality of the recombined milk products can be avoided by reducing the lactose content of the milk-based formulation before concentrating it to a form suitable for recombination. As the amount of the products produced in lactose hydrolysis of milk, involving in the Maillard reaction, are reduced, the Maillard reaction is significantly suppressed and the typical problems associated therewith are avoided.
- the shelf life of the recombined milk products of the inventions, especially at a room temperature, is prolonged.
- the invention provides a process for producing a milk-based formulation of the invention, comprising removing carbohydrates from a milk raw material to provide the milk-based formulation with a reduced carbohydrate content.
- the invention provides a process for produc- ing a milk-based formulation of the invention, comprising
- the invention provides a use of milk powder having a ratio of carbohydrates to protein of at most 1 .1 and a protein content of at least 5.4% on dry matter basis for the preparation of a recombined milk product with a reduced carbohydrate content.
- the milk powder of the invention enables to prepare lactose-free milk with good taste without investments in equipment in the plant where the lactose- free milk is prepared.
- Lactose-free milk can be prepared from the milk powder of the invention and water and/or normal milk. Due to the favourable composition of the milk powder it can be dried to powder with reduced Maillard reactions. Quantity of the recombined milk product prepared from the milk powder of the inven- tion is thus improved.
- the invention provides a process for producing a recombined milk product having a reduced carbohydrate content, comprising recombining milk powder having a ratio of carbohydrates to protein of at most 1 .1 and a protein content of at least 5.4% on dry matter basis, and a liquid and optional other ingredients to provide the recombined milk product with a reduced carbohydrate content.
- the composition of the recombined milk product can be adjusted to correspond to that of normal milk except for lactose by combining the milk powder and liquid without any further additives, like mineral supplement.
- the invention provides a process that is simple, economic, industrially applicable on a large scale, and does not cause additional cost.
- the invention also provides a process which brings remarkable savings in transportation cost.
- the invention further provides a process which allows to control the adverse effects of recombination in an economical, efficient and simple manner.
- recombined milk products is used herein to mean milk products which are prepared by recombining a milk-based formulation with a liquid. Further ingredients, like milk fat (cream, butter) can be incorporated into the recombined milk product in order to obtain a desired fat content of the product. Formulation can also be produced with a desired fat, protein and mineral content.
- liquid is used herein to mean water, a milk raw material, or plant (vegetable) origin material, or a combination of these.
- the liquid can be, for instance, side streams obtained from manufacturing process of milk products, such as rinsing waters (washing waters) derived from streams obtained from washing/rinsing of processing pipes, containers and vessels in dairy and plant (vegetable) product manufacturing plants.
- side streams include UF permeates, NF permeates, RO permeates, RO retentates, diawater, or mixtures thereof.
- the liquid is water, skim milk or RO-retentate.
- milk raw material is used herein to mean to milk, whey, and combinations of milk and whey as such obtained from an animal, such as a cow, sheep, goat, camel, mare or any other animal that produces milk suitable for human consumption, or milk that is pre-processed as desired, for example as a concentrate.
- the milk may be supplemented with ingredients generally used in the preparation of milk products, such as fat, protein or sugar fractions, or the like.
- the milk may thus be, for instance, full-fat milk, cream, low-fat milk or skim milk, ultrafiltered milk, diafiltered milk, microfiltered milk or milk recombined from milk powder, organic milk or a combination of these.
- the milk raw material can be, for instance, side streams obtained from manufacturing process of milk products.
- the milk raw material is skim milk.
- the invention provides a milk-based formulation with a reduced carbohydrate composition, having a ratio of carbohydrates to protein of at most 1 .1 , a protein content of at least 5.4% on dry matter basis, and a ratio of ash to protein is substantially similar to that of a milk raw material used as a starting material.
- the formulation has a dry matter content of 8 to 60%.
- the formulation is powder.
- the dry matter content of powder is typically in the range from 94 to 100%.
- An ash to protein ratio of the formulation has a significant effect on the organoleptic properties, especially on taste, of the formulation.
- ash is provided as milk-based minerals in the formulation.
- the ratio of carbohydrates to protein is at most 0.9. In another embodiment, the ratio of carbohydrates to protein is at most 0.4. In still another embodiment, the ratio of carbohydrates to protein is at least 0.02.
- the milk-based formulation comprises 5.4 to 80% protein on dry matter basis.
- a ratio of the monovalent minerals of milk to pro- tein is substantially similar to that of the milk raw material.
- the milk-based formulation is powder.
- the protein content of natural milk can vary within quite a wide range, depending on animal species, breed, feeding and season, etc.
- the protein content of milk obtained from cows can vary between 1 .8 to 6.3%.
- the milk-based formulation comprises 5.4 to 65% protein, 4.6 to 41 % carbohydrates, and 1 .0 to 14% ash on non-fat total solid basis. In another embodiment, the milk-based formulation comprises about 48 to 60% protein, about 24 to 43% carbohydrates, and 10 to 13% ash.
- the carbohydrate content of the milk raw material can be reduced by any manner known in the art. Carbohydrates present in natural milk are primarily lactose. Prior to lactose removal, the fat content of the milk raw material may be reduced.
- the invention provides a process for preparing a milk-based formulation of the invention, with a reduced carbohydrate content, comprising removing carbohydrates from a milk raw material to provide the milk- based formulation with a reduced carbohydrate content.
- the milk-based formulation is concentrated to powder by an appropriate process, for example by spray drying.
- lactose is removed from the milk raw material by precipitation.
- the precipitation can be performed in a manner commonly known in the art. Precipitation of lactose allows to efficiently remove lactose from a milk raw material while all the other milk components are substantially retained in a desired manner.
- the lactose removal can be performed by means of enzymatic reactions.
- Conventional enzymatic processes for splitting lactose, or for conversion of lactose to derivatives, such as lactulose, lactitol, lactobionic acid and their degradation products are generally known in the field.
- the process for splitting lactose comprising the step of adding lactase from fungus or yeast to milk in such a manner that lactose is split into monosaccharides, i.e. glucose and galactose, in over 80%.
- Enzymes typically catalyse several types of reactions, i.e. lactase both hydrolysis and transglucosylation reactions.
- lactose is removed from the milk raw ma- terial by chromatographic separation.
- the milk raw material is eluated through a column filled with a cation exchange resin.
- the separation can be carried out so that a significant portion of the proteins and minerals are collected into a single fraction whereas lactose remains in the column.
- lactose is removed from the milk raw ma- terial by means of a membrane filtration technique.
- membranes with different cut-off values allows to efficiently separate the various milk components, i.e. proteins, carbohydrates and minerals, from each other into different fractions.
- the invention provides a process for preparing a milk-based formulation of the invention, with a reduced carbohydrate content, comprising
- the milk-based formulation prepared above is concentrated to powder.
- ultrafiltration is typically used for separating the proteins and fat from lactose and minerals of milk.
- the fat content of milk can be standardized for example by separation.
- the milk proteins, and any fat, remain in the ultrafiltration retentate whereas lactose and minerals pass into a permeate.
- Ultrafiltration is typically carried out by a concentration factor of 1 to 10.
- Lactose and the monovalent minerals, mainly sodium and potassium, present in the ultrafiltration permeate can be separated from each other by nanofiltration. Lactose remains in a nanofiltration retentate, and the monovalent minerals pass into a nanofiltration permeate.
- the concentration factor of nanofil- tration is typically in the range of 1 to 6.
- the nanofiltration permeate solution including the monovalent minerals can be concentrated by reverse osmosis to provide a mineral concentrate for use in the milk-based formulation of the invention.
- Reverse osmosis is generally carried out by a concentration factor of 2 to 20.
- the dry matter content of the milk protein fraction and/or the milk mineral fraction obtained from membrane filtrations can be increased by evaporation, for example to about 17%, and use the evaporated fraction ⁇ ) for the preparation of the milk-based formulation.
- milk-based formulation where all the other milk components except for lactose are retained in the composition.
- Membrane filtration technology further provides the possibility to separate lactose and milk minerals, mainly monovalent minerals, from each other and to separately compose an optimized and tailor-made milk-based formulation of the invention from the protein and mineral fractions.
- one or more of the milk component fractions are separately concentrated to powder by an appropriate process and then used for preparing the milk-based formulation of the invention with a desired composition.
- the milk-based formulation is first prepared from said frac- tions in an appropriate manner and then dried to powder.
- the invention provides a use of milk powder having a ratio of carbohydrates to protein of at most 1 .1 and a protein content of at least 5.4% on dry matter basis for the preparation of a recombined milk product with a reduced carbohydrate content.
- a ratio of ash to protein is sub- stantially similar to that of a milk raw material used as a starting material.
- the protein content of the milk powder is at least 37%. In another embodiment, the protein content is at least 45%.
- the recombined milk product is a milk beverage.
- the milk powder is the milk-based formulation of the invention, or prepared by the process of the invention described above.
- the amount of the milk powder in the recombined milk product is 0.5 to 15% by weight, preferably 2 to 7% by weight.
- the invention provides a process for producing a recombined milk product having a reduced carbohydrate content, comprising recombining milk powder having a ratio of carbohydrates to protein of at most 1 .1 and a protein content of at least 5.4% on dry matter basis, and a liquid and optional other ingredients to provide the recombined milk product with a reduced carbohydrate content.
- the protein content of the milk powder is at least 37%. In another embodiment, the protein content is at least 45%.
- the process of the invention may be applied to an industrial large- scale production or to a small-scale production in households.
- the lactose content of the recombined milk product is at most 3.1 % by weight.
- the milk powder can be recombined in a liquid which can be water, a milk raw material, plant (vegetable) origin material, or a mixture thereof.
- the recombined milk is prepared so as correspond to composition of normal skim milk except for reduced carbohydrates.
- an ash to protein ratio of the recombined milk product is similar to that of normal skim milk.
- ash is provided as milk-based minerals in the recombined milk product.
- the composition of the recombined milk product can be adjusted to correspond to that of normal skim milk except for reduced carbohydrates by combining the milk powder and liquid without any further additives, like mineral supplement. However, also milk-based minerals can be added to the recombined milk product.
- the recombined milk product of the invention can be supplemented with ingredients typically used in milk product.
- Optional ingredients include edible fat, like milk fat or vegetable fat such as rapeseed oil, fractionated palm oil or coconut oil, vitamins, minerals, fibre, probiotics, flavours.
- the recombined milk product is prepared by re- combining powder 1 of the invention with skim milk and water. In another embodiment, the recombined milk product is prepared by recombining 2.4% of powder 1 , 54% of skim milk and 43.6% of water.
- the recombined milk product is subjected to a heat treatment.
- the heat treatment can be performed, for example, at a temperature of 153°C for 4 seconds.
- any residual lactose present in the recombined milk product is subjected to lactose hydrolysis and/or conversion.
- the lactose hydrolysis and/or conversion can be performed with commercially available lactase enzymes in a manner known per se.
- the lactose content of the recombined milk product is less than 1 % by weight, generally designated as a low lactose milk beverage. In another embodiment, the lactose content is less than 0.01 % by weight, generally designated as a lactose-free milk beverage.
- Lactose hydrolysis can be performed on the recombined milk product which has been heat treated in a manner described above, or on the recombined milk product which is subsequently subjected to the heat treatment. In an embodiment, the lactose hydrolysis is performed after the heat treatment.
- the furosine content of the recombined milk beverages prepared according to the invention were measured before and after the heat treatment of the beverages.
- the furosine content was compared to that of skim milk (bever- age 6) and a recombined skim milk prepared by recombining conventional skim milk powder and water (beverage 7), which were used as references.
- the furosine contents of the beverages prepared from the milk compositions of the invention were lower than that of the reference recombined skim milk both before and after the heat treatment.
- the furosine contents were significantly lower than that of the refer- ence recombined skim milk.
- the furosine content of the recombined milk product of the invention is at most 0.61 mg/g protein prior to heat treatment of the product. In another embodiment, the furosine content of the recombined milk product of the invention is at most 0.92 mg/g protein after heat treatment of the product.
- the organoleptic properties of the recombined milk product prepared according to the invention unexpectedly keep at room temperature even during a long storage.
- the process is easy to perform in production conditions without significant extra costs.
- Skim milk was ultrafiltered with a GR61 PP membrane (Dow, USA) at a temperature of 10°C and with a concentration factor of 4 to provide an ultrafiltration (UF) permeate and an ultrafiltration (UF) retentate.
- the UF permeate was further nanofiltered with a Desal DK membrane (Osmonics, USA) at temperatures from 10°C to 15°C and with a concentration factor of 4 to provide a nanofil- tration (NF) permeate and a nanofiltration (NF) retentate.
- the NF permeate was concentrated by reverse osmosis (RO) with a Filmtec RO-390-FF membrane (Dow, USA) and with a concentration factor of about 10 to provide an RO permeate and RO retentate.
- RO reverse osmosis
- the RO retentate was evaporated to a dry matter content of 17%.
- the compositions of the milk raw material, i.e. skim milk, the UF retentate and permeate, the RO retentate, and the evaporated RO retentate are given in Table 1 below. Table 1.
- the evaporated RO retentate (700 kg) and the UF retentate (10 000 kg) were mixed together and evaporated to a dry matter concent of 33% to 40%.
- the resultant mixture was dried to powder (powder 1 ) with a corresponding heat treatment of the conventional low-heat milk powder.
- the UF retentate obtained from ultrafiltration of skim milk was evaporated and dried to powder (powder 2) with a corresponding heat treatment of the conventional low-heat milk powder.
- compositions of powder 1 and powder 2 are given in Table 2 below.
- Skim milk was ultrafiltered in a manner described in Example 1 except that the concentration factor was 1 .6 to provide an UF retentate.
- Cheese whey was nanofiltered with a Desal DK membrane (Osmon- ics, USA) at a temperature ⁇ 15°C and with a concentration factor of 4.5 to provide a nanofiltration (NF) permeate and a nanofiltration (NF) retentate.
- the NF permeate was concentrated by reverse osmosis (RO) as described in Example 1 .
- the RO retentate obtained was evaporated to a dry matter content of 17.5%.
- compositions of the UF retentate, the cheese whey, the RO retentate, and the evaporated RO retentate are given in Table 3 below.
- Skim milk was evaporated to provide a milk concentrate with a dry matter content of 30%.
- the milk concentrate was pumped to a chromatography column filled with a cation exchange resin.
- Skim milk eluated through the cation exchange resin was collected so that a significant portion of milk minerals and proteins were in the same fraction.
- the chromatographic separation was performed at a temperature of about 60°C.
- the fraction obtained from the chromatographic separation was dried to powder (powder 4) as described in Example 1 .
- composition of the collected fraction from chromatography and powder 4 are given in Table 5 below.
- milk and low-heat milk powder were used in the preparation of the beverages. Their compositions are given in Table 6. Table 6.
- the beverages were pasteurized with a direct steam infusion UHT (ultra high temperature) equipment (APV, Denmark) at a temperature of 153°C for 4 seconds.
- the beverages were packed aseptically.
- Prior to packing 0.03% by weight of lactase (Godo YNL2, Oenon, Japan) was added aseptically to the bev- erages.
- the milk beverages were lactose-free after one week storage.
- the composition of the above nine beverages are given in Table 8.
- the beverages having a temperature of about 15°C were evaluated in their organoleptic properties after about one week after preparation thereof. Results of the evaluation are given in Table 9. The organoleptic properties were compared to normal skim milk (beverage 6) including natural lactose con- tent.
- beverage 4 was similar to that of normal milk except that it was slightly watery. The biggest de- viations in taste were found in beverages 6 and 7 which were notably sweet and did not correspond in their properties to normal UHT-treated milk. Moreover, each beverage 2 to 9 except 5 was further prepared by supplementing them with cream (38%) to provide a fat content of 1 .5% to the beverage.
- Powder 1 according to Example 1 was prepared from milk by ultrafil- tering milk containing fat 3.1 % and drying the UF-retentate to powder which was used in similar manner as powder 1 in the preparation of beverages 1 and 5.
- Beverages 1 and 5 had fat content of 1 .5%.
- a lactose-free milk beverage of the invention prepared from powder 1 produced in Example 1 has a better taste than the recombined milk prepared from normal skim milk powder (beverage 7; reference). Moreover, the furosine content of the beverage of the invention is substantially lower than that of the reference milk. Moreover, surprisingly, the taste and texture remained better in the beverage of the invention than in the normal UHT-treated skim milk.
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Water Supply & Treatment (AREA)
- Microbiology (AREA)
- Dairy Products (AREA)
- Non-Alcoholic Beverages (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
Claims
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI201231640T SI2729012T1 (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
MX2013015232A MX368479B (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation. |
ES12761639T ES2739807T3 (en) | 2011-07-06 | 2012-06-19 | Milk based formulation |
KR1020147001761A KR20140041792A (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
JP2014517855A JP6539044B2 (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
CA2839981A CA2839981C (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
US14/131,096 US20140205718A1 (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
PL12761639T PL2729012T3 (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
LTEP12761639.9T LT2729012T (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
EP12761639.9A EP2729012B1 (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
CN201280033088.6A CN103635092B (en) | 2011-07-06 | 2012-06-19 | Breast based formulation |
BR112014000077-8A BR112014000077B1 (en) | 2011-07-06 | 2012-06-19 | MILK POWDER, PROCESS FOR PREPARING IT, PROCESS FOR PRODUCING A MILK PRODUCT, AND ITS USE |
DK12761639.9T DK2729012T3 (en) | 2011-07-06 | 2012-06-19 | MILK-BASED FORMULATION |
AU2012280182A AU2012280182B2 (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
RU2014104031A RU2623173C2 (en) | 2011-07-06 | 2012-06-19 | Composition on basis of milk |
IL230305A IL230305A (en) | 2011-07-06 | 2014-01-02 | Milk-based formulation |
US16/774,674 US11653662B2 (en) | 2011-07-06 | 2020-01-28 | Milk-based formulation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20115726 | 2011-07-06 | ||
FI20115726A FI124711B (en) | 2011-07-06 | 2011-07-06 | Milk-based formulation |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/131,096 A-371-Of-International US20140205718A1 (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
US16/774,674 Division US11653662B2 (en) | 2011-07-06 | 2020-01-28 | Milk-based formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013004895A1 true WO2013004895A1 (en) | 2013-01-10 |
Family
ID=44318396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FI2012/050634 WO2013004895A1 (en) | 2011-07-06 | 2012-06-19 | Milk-based formulation |
Country Status (23)
Country | Link |
---|---|
US (2) | US20140205718A1 (en) |
EP (1) | EP2729012B1 (en) |
JP (3) | JP6539044B2 (en) |
KR (1) | KR20140041792A (en) |
CN (1) | CN103635092B (en) |
AR (1) | AR087059A1 (en) |
AU (1) | AU2012280182B2 (en) |
BR (1) | BR112014000077B1 (en) |
CA (1) | CA2839981C (en) |
CL (1) | CL2014000006A1 (en) |
DK (1) | DK2729012T3 (en) |
ES (1) | ES2739807T3 (en) |
FI (1) | FI124711B (en) |
HU (1) | HUE044654T2 (en) |
IL (1) | IL230305A (en) |
LT (1) | LT2729012T (en) |
MX (1) | MX368479B (en) |
PL (1) | PL2729012T3 (en) |
PT (1) | PT2729012T (en) |
RU (1) | RU2623173C2 (en) |
SI (1) | SI2729012T1 (en) |
TR (1) | TR201911240T4 (en) |
WO (1) | WO2013004895A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104286170A (en) * | 2014-09-16 | 2015-01-21 | 陕西师范大学 | Dairy product capable of improving learning and memory abilities as well as preparation method and application of dairy product |
WO2015099542A1 (en) | 2013-12-23 | 2015-07-02 | Goodman Fielder New Zealand Limited | An improved beverage and method of manufacture |
WO2022157420A1 (en) | 2021-01-21 | 2022-07-28 | Valio Ltd | Milk powder composition |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI124711B (en) * | 2011-07-06 | 2014-12-15 | Valio Oy | Milk-based formulation |
EP3788881B1 (en) | 2016-12-02 | 2022-07-06 | Fairlife, LLC | Non-browning lactose-free milk powder and methods of making same |
EP3542634B1 (en) * | 2018-03-21 | 2021-06-30 | DMK Deutsches Milchkontor GmbH | Milk protein concentrates with reduced ash content |
EP3620058A1 (en) | 2018-09-10 | 2020-03-11 | FrieslandCampina Nederland B.V. | Use of bovine milk fat fraction to enhance taste |
US11503836B2 (en) | 2020-10-20 | 2022-11-22 | Michael J. McCloskey | Process for making lactose-free milk powders |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0203706A2 (en) * | 1985-04-23 | 1986-12-03 | Valio Meijerien Keskusosuusliike | A milk preparation suitable for diabetics and lactose-intolerant persons, and a process for preparing it |
WO1996008155A1 (en) * | 1994-09-16 | 1996-03-21 | New Zealand Dairy Board | Physical separation of casein and whey proteins |
WO2003094623A1 (en) * | 2002-05-14 | 2003-11-20 | Valio Ltd | Process for producing a lactose-free milk product |
US20040040448A1 (en) * | 2002-08-27 | 2004-03-04 | Dunker John M. | Dairy compositions and method of making |
US20050181095A1 (en) * | 2004-02-18 | 2005-08-18 | Dominion Nutrition, Inc. | Concentrated-protein food product and process |
US20070104847A1 (en) * | 2005-11-09 | 2007-05-10 | O'mahony James A | Purification of beta casein from milk |
US20070166447A1 (en) * | 2002-08-27 | 2007-07-19 | Select Milk Producers, Inc. | Dairy compositions and method of making |
WO2009043356A1 (en) | 2007-10-03 | 2009-04-09 | Arla Foods Amba | Process for producing lactose-free milk |
US20100055286A1 (en) | 2008-08-29 | 2010-03-04 | Valio Ltd. | Low-lactose and lactose-free milk product and process for production thereof |
US20110097442A1 (en) * | 2009-10-28 | 2011-04-28 | Valio Oy | Whey protein product and a method for its preparation |
WO2011051557A1 (en) * | 2009-10-28 | 2011-05-05 | Valio Ltd | Whey protein product and a method for its preparation |
EP2729012A1 (en) | 2011-07-06 | 2014-05-14 | Valio Ltd | Milk-based formulation |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2125137A1 (en) | 1971-02-12 | 1972-09-29 | Genvrain Sa | Delactosed milk prepn - by ultra filtration of milk followed by inverse osmosis to separate lactose |
DE3275970D1 (en) | 1982-11-15 | 1987-05-14 | Holland Melkunie | Pulverized products, containing little lactose |
FI73000C (en) * | 1985-11-14 | 1987-08-10 | Valio Meijerien | Procedure for specific separation of lactose from milk. |
GB2212380A (en) | 1987-11-19 | 1989-07-26 | Danish Fancy Food Group As | Milk concentrate and process for the preparation thereof |
JPH08256682A (en) * | 1995-03-24 | 1996-10-08 | Snow Brand Milk Prod Co Ltd | Production of low lactose powdered milk |
JP3290145B2 (en) | 1998-09-30 | 2002-06-10 | 雪印乳業株式会社 | Milk material and method for producing the same |
ES2226466T3 (en) * | 1998-11-24 | 2005-03-16 | Societe Des Produits Nestle S.A. | PROCEDURE FOR PREPARATION OF A PROTEIN COMPOSITION AND A CHILD FORMULA CONTAINING IT. |
CA2260673A1 (en) | 1999-02-04 | 2000-08-04 | Natrel Inc. | A process for making a lactose-free milk without negatively affecting the organoleptic properties thereof; and milk so processed |
US6875459B2 (en) * | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
CA2456790A1 (en) | 2004-02-03 | 2005-08-03 | Saputo Inc. | Lactose-free milk and process for making same |
FI120616B (en) * | 2005-02-18 | 2009-12-31 | Valio Oy | Energy-low fat-free milk drink with high calcium content and process for making it |
CN1899054A (en) * | 2006-07-17 | 2007-01-24 | 颜贻谦 | Method for making sugar-removing milk |
FI120953B (en) | 2007-06-26 | 2010-05-31 | Valio Oy | Process for the preparation of a well-preserved low lactose or lactose-free milk product |
CN101491287B (en) * | 2008-01-24 | 2012-05-23 | 滕国新 | Method for extracting lactose and lactoalbumin from whey and producing formulation milk powder |
KR20110073485A (en) | 2008-08-29 | 2011-06-29 | 발리오 리미티드 | Low-lactose and lactose-free milk product and process for production thereof |
JP5514422B2 (en) * | 2008-09-24 | 2014-06-04 | 雪印メグミルク株式会社 | milk beverage |
AU2010238184B2 (en) | 2009-04-15 | 2014-09-04 | Glanbia Nutritionals (Ireland) Limited | A reduced lactose milk product and a process for the preparation thereof |
MX356991B (en) | 2010-07-23 | 2018-06-22 | Arla Foods Amba Star | Lactose-reduced milk-related product, and a process and milk processing plant for its manufacture. |
-
2011
- 2011-07-06 FI FI20115726A patent/FI124711B/en active IP Right Grant
-
2012
- 2012-06-19 EP EP12761639.9A patent/EP2729012B1/en not_active Revoked
- 2012-06-19 LT LTEP12761639.9T patent/LT2729012T/en unknown
- 2012-06-19 CA CA2839981A patent/CA2839981C/en active Active
- 2012-06-19 PT PT12761639T patent/PT2729012T/en unknown
- 2012-06-19 MX MX2013015232A patent/MX368479B/en active IP Right Grant
- 2012-06-19 HU HUE12761639 patent/HUE044654T2/en unknown
- 2012-06-19 US US14/131,096 patent/US20140205718A1/en not_active Abandoned
- 2012-06-19 JP JP2014517855A patent/JP6539044B2/en active Active
- 2012-06-19 DK DK12761639.9T patent/DK2729012T3/en active
- 2012-06-19 KR KR1020147001761A patent/KR20140041792A/en active Search and Examination
- 2012-06-19 AU AU2012280182A patent/AU2012280182B2/en active Active
- 2012-06-19 RU RU2014104031A patent/RU2623173C2/en active
- 2012-06-19 SI SI201231640T patent/SI2729012T1/en unknown
- 2012-06-19 BR BR112014000077-8A patent/BR112014000077B1/en active Search and Examination
- 2012-06-19 TR TR2019/11240T patent/TR201911240T4/en unknown
- 2012-06-19 ES ES12761639T patent/ES2739807T3/en active Active
- 2012-06-19 WO PCT/FI2012/050634 patent/WO2013004895A1/en active Application Filing
- 2012-06-19 CN CN201280033088.6A patent/CN103635092B/en active Active
- 2012-06-19 PL PL12761639T patent/PL2729012T3/en unknown
- 2012-07-04 AR ARP120102426A patent/AR087059A1/en active IP Right Grant
-
2014
- 2014-01-02 IL IL230305A patent/IL230305A/en active IP Right Grant
- 2014-01-03 CL CL2014000006A patent/CL2014000006A1/en unknown
-
2017
- 2017-09-11 JP JP2017174097A patent/JP7094675B2/en active Active
-
2020
- 2020-01-28 US US16/774,674 patent/US11653662B2/en active Active
-
2022
- 2022-02-18 JP JP2022023727A patent/JP7367095B2/en active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0203706A2 (en) * | 1985-04-23 | 1986-12-03 | Valio Meijerien Keskusosuusliike | A milk preparation suitable for diabetics and lactose-intolerant persons, and a process for preparing it |
WO1996008155A1 (en) * | 1994-09-16 | 1996-03-21 | New Zealand Dairy Board | Physical separation of casein and whey proteins |
WO2003094623A1 (en) * | 2002-05-14 | 2003-11-20 | Valio Ltd | Process for producing a lactose-free milk product |
US20040040448A1 (en) * | 2002-08-27 | 2004-03-04 | Dunker John M. | Dairy compositions and method of making |
US20070166447A1 (en) * | 2002-08-27 | 2007-07-19 | Select Milk Producers, Inc. | Dairy compositions and method of making |
US20050181095A1 (en) * | 2004-02-18 | 2005-08-18 | Dominion Nutrition, Inc. | Concentrated-protein food product and process |
US20070104847A1 (en) * | 2005-11-09 | 2007-05-10 | O'mahony James A | Purification of beta casein from milk |
WO2009043356A1 (en) | 2007-10-03 | 2009-04-09 | Arla Foods Amba | Process for producing lactose-free milk |
US20100055286A1 (en) | 2008-08-29 | 2010-03-04 | Valio Ltd. | Low-lactose and lactose-free milk product and process for production thereof |
US20110097442A1 (en) * | 2009-10-28 | 2011-04-28 | Valio Oy | Whey protein product and a method for its preparation |
WO2011051557A1 (en) * | 2009-10-28 | 2011-05-05 | Valio Ltd | Whey protein product and a method for its preparation |
EP2729012A1 (en) | 2011-07-06 | 2014-05-14 | Valio Ltd | Milk-based formulation |
Non-Patent Citations (2)
Title |
---|
ANONYMOUS: "Milk Carbohydrate (Lactose)", MILK FACTS, 24 March 2017 (2017-03-24), pages 1 - 2, XP055366730, Retrieved from the Internet <URL:http://www.milkfacts.info/Milk Composition/Carbohydrate.htm> |
ANONYMOUS: "Milk Composition - Lactose", MILK COMPOSITION & SYNTHESIS RESOURCE LIBRARY, 24 March 2017 (2017-03-24), pages 1 - 2, XP055366732, Retrieved from the Internet <URL:http://ansci.illinois.edu/static/ansc438/Milkcompsynth/milkcomp_lactose.html> |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015099542A1 (en) | 2013-12-23 | 2015-07-02 | Goodman Fielder New Zealand Limited | An improved beverage and method of manufacture |
CN106061276A (en) * | 2013-12-23 | 2016-10-26 | 古德曼菲尔德新西兰有限公司 | An improved beverage and method of manufacture |
GB2542242A (en) * | 2013-12-23 | 2017-03-15 | Goodman Fielder New Zealand Ltd | An improved beverage and method of manufacture |
EP3086652A4 (en) * | 2013-12-23 | 2017-08-02 | Goodman Fielder New Zealand Limited | An improved beverage and method of manufacture |
AU2014370523B2 (en) * | 2013-12-23 | 2019-02-28 | Goodman Fielder Pte. Limited | An improved beverage and method of manufacture |
CN106061276B (en) * | 2013-12-23 | 2020-01-14 | 固德曼费尔德私人有限公司 | Improved beverage and method of preparation |
GB2542242B (en) * | 2013-12-23 | 2021-02-10 | Goodman Fielder Pte Ltd | Method of manufacturing a powdered or liquid dairy product |
CN104286170A (en) * | 2014-09-16 | 2015-01-21 | 陕西师范大学 | Dairy product capable of improving learning and memory abilities as well as preparation method and application of dairy product |
WO2022157420A1 (en) | 2021-01-21 | 2022-07-28 | Valio Ltd | Milk powder composition |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11653662B2 (en) | Milk-based formulation | |
JP6932815B2 (en) | Dairy formulation and its manufacturing method | |
CA2827463C (en) | Milk-based product and a method for its preparation | |
US10080372B2 (en) | Low-lactose and lactose-free milk product and process for production thereof | |
US20140302219A1 (en) | Method for producing a milk product | |
US20100055286A1 (en) | Low-lactose and lactose-free milk product and process for production thereof | |
EP3496543B1 (en) | Process for producing infant formula products and dairy products | |
KR102524607B1 (en) | Process for producing lactose-free milk | |
WO2018028764A1 (en) | Process for producing infant formula products and acidic dairy products | |
WO2018115586A1 (en) | Product and process for its preparation | |
WO2010023361A2 (en) | Low-lactose and lactose-free milk product and process for production thereof | |
WO2022147094A1 (en) | Dairy creamer with a low carbohydrate content |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201280033088.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12761639 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2839981 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2013/015232 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2014517855 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014000006 Country of ref document: CL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012761639 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20147001761 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14131096 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2014104031 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2012280182 Country of ref document: AU Date of ref document: 20120619 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014000077 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112014000077 Country of ref document: BR Kind code of ref document: A2 Effective date: 20140103 |